slides · global inventory
Consultants Gambit
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 39,432
Current window 31,861-31,890
Pages 1,315
Rows per page 30
Arc
31,861-31,890 of 39,432
01
Alkermes | Results Presentation Deck | 31 slidesAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Situation & Context1 hit
02
Alkermes | Results Presentation Deck | 31 slidesAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Situation & Context1 hit
03
Alkermes | Results Presentation Deck | 31 slidesAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Situation & Context1 hit
04
Alkermes | Results Presentation Deck | 31 slidesAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Situation & Context1 hit
05
The slide uses a human body diagram to map clinical response areas.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
06
RP2D: Recommended Phase 2 DoseAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
07
The slide uses a table-like structure to organize clinical trial programs by name, phase, and study details.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
08
Alkermes | Results Presentation Deck | 31 slidesAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
09
The slide uses a process flow diagram to show how patients move from dose escalation (Part A) to expansion (Part B) and combination therapy (Part C).Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
10
Data as of March 19, 2021.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
11
Slide provides status update on clinical trial enrollment as of May 25, 2021.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
12
The chart is a swimmer plot, a common clinical trial visualization for patient-level response over time.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
13
Data cut off May 3, 2021.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
14
The chart is a swimmer plot, a common visualization in oncology clinical trials to show patient-level treatment duration and response.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
15
Data cut off May 3, 2021. PR = Partial Response.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
16
The slide details specific patient cohorts categorized by dosage and tumor type/treatment history.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
17
Data cut off May 3, 2021. Includes patient-level data for 7 patients.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
18
The chart displays individual patient responses categorized by tumor type. Stable disease is indicated by the shaded region between -30% and +20%.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
19
Data cut off May 3, 2021.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
20
The chart uses a waterfall plot format to visualize clinical trial efficacy data across multiple tumor types.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
21
Includes clinical trial abbreviations at the bottom.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
22
Alkermes | Results Presentation Deck | 31 slidesAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
23
The slide outlines the transition from dose-finding cohorts to a specific expansion phase.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
24
The slide uses a three-column layout to summarize clinical trial safety data.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
07
Slide 7 of a deck, likely from a Thermo Fisher acquisition presentation.Thermo Fisher | Mergers and Acquisitions Presentation Deck | 12 slides · Thermo Fisher Scientific
Deck Investment bank Beat · Evidence & ProofLoop · Golden Circle1 hit
08
The slide uses a 'donut chart' expansion to show the proforma increase in market share, and a bar chart with an arrow to indicate growth.Thermo Fisher | Mergers and Acquisitions Presentation Deck | 12 slides · Thermo Fisher Scientific
Deck Investment bank Beat · Evidence & ProofLoop · Golden Circle1 hit
09
The slide uses a process flow diagram to illustrate the end-to-end support provided to customers.Thermo Fisher | Mergers and Acquisitions Presentation Deck | 12 slides · Thermo Fisher Scientific
Deck Investment bank Beat · Impact & Next StepsLoop · Golden Circle1 hit
10
Thermo Fisher | Mergers and Acquisitions Presentation Deck | 12 slidesThermo Fisher | Mergers and Acquisitions Presentation Deck | 12 slides · Thermo Fisher Scientific
Deck Investment bank Beat · Impact & Next StepsLoop · Golden Circle1 hit
11
Thermo Fisher | Mergers and Acquisitions Presentation Deck | 12 slidesThermo Fisher | Mergers and Acquisitions Presentation Deck | 12 slides · Thermo Fisher Scientific
Deck Investment bank Beat · Impact & Next StepsLoop · Golden Circle1 hit
12
Thermo Fisher | Mergers and Acquisitions Presentation Deck | 12 slidesThermo Fisher | Mergers and Acquisitions Presentation Deck | 12 slides · Thermo Fisher Scientific
Deck Investment bank Beat · Impact & Next StepsLoop · Golden Circle1 hit